A carregar...

The cancer therapeutic potential of Chk1 inhibitors: how mechanistic studies impact on clinical trial design

Many anticancer agents damage DNA and activate cell cycle checkpoints that permit time for the cells to repair their DNA and recover. These checkpoints have undergone intense investigation as potential therapeutic targets and Chk1 inhibitors have emerged as promising novel therapeutic agents. Chk1 w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Thompson, Ruth, Eastman, Alan
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Science Inc 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3769664/
https://ncbi.nlm.nih.gov/pubmed/23593991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12139
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!